You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 69452-0233


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 69452-0233

Drug NameNDCPrice/Unit ($)UnitDate
PROGESTERONE 100 MG CAPSULE 69452-0233-20 0.25973 EACH 2025-03-19
PROGESTERONE 100 MG CAPSULE 69452-0233-20 0.24029 EACH 2025-02-19
PROGESTERONE 100 MG CAPSULE 69452-0233-20 0.21680 EACH 2025-01-22
PROGESTERONE 100 MG CAPSULE 69452-0233-20 0.21062 EACH 2024-12-18
PROGESTERONE 100 MG CAPSULE 69452-0233-20 0.17972 EACH 2024-11-20
PROGESTERONE 100 MG CAPSULE 69452-0233-20 0.25015 EACH 2024-10-23
PROGESTERONE 100 MG CAPSULE 69452-0233-20 0.27102 EACH 2024-09-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 69452-0233

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
PROGESTERONE 100MG CAP AvKare, LLC 69452-0233-20 100 22.64 0.22640 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for NDC 69452-0233: Progesterone

Overview of NDC 69452-0233

The National Drug Code (NDC) 69452-0233 corresponds to a 100 mg oral capsule of Progesterone, a human prescription drug labeled and distributed by Bionpharma Inc.[4].

Market Context

Pharmaceutical Expenditures Trends

The pharmaceutical market is experiencing significant growth, with overall prescription drug expenditures in the US increasing by 13.6% in 2023 compared to the previous year. This growth is driven by factors such as increased utilization, new drug approvals, and price increases[3].

Specific Drug Categories

Progesterone, as a hormone replacement therapy, falls under the broader category of endocrine drugs. Endocrine drugs are among the categories expected to drive pharmaceutical expenditures in the coming years, particularly with the rise in demand for hormone therapies[3].

Pricing Dynamics

Current Pricing

As of the latest data, the price per unit for Progesterone 100 mg capsules with the NDC 69452-0233 is approximately $0.21 per capsule. This pricing is consistent across various vendors and formulations[5].

Price Trends

The pharmaceutical industry has seen significant price fluctuations, especially for generic drugs. For instance, a generic version of naproxen experienced a 2,527% price increase between 2012 and 2021, highlighting the volatility in drug pricing[2].

Projections

Given the overall trend of increasing pharmaceutical expenditures, it is likely that prices for Progesterone and similar drugs will continue to rise, albeit at a more moderate pace. The median price increase for generic drugs was 19.9% in 2022, which could serve as a benchmark for future price adjustments[2].

Regulatory and Transparency Aspects

FDA Reporting and NDC Directory

The FDA's National Drug Code Directory includes detailed information on drugs like Progesterone, including their marketing start and end dates, and any updates or corrections to their listings. This transparency helps in tracking price and availability changes over time[1].

Drug Price Transparency

Efforts to enhance drug price transparency, such as those in Oregon, aim to provide clearer insights into the factors influencing drug prices. These initiatives include reporting on price increases, discounts, and other cost factors that impact consumer costs. While these measures are still evolving, they could potentially stabilize or reduce price volatility in the future[2].

Market Factors Influencing Price

Utilization and Demand

Increased utilization of hormone replacement therapies, including Progesterone, can drive up demand and subsequently affect pricing. The growth in clinics and hospitals, particularly in the endocrine drug category, suggests a steady demand for such medications[3].

New Drug Approvals and Patent Expirations

New drug approvals and patent expirations can significantly impact the pricing landscape. The introduction of new drugs or the expiration of patents on existing ones can lead to increased competition, potentially stabilizing or reducing prices[3].

Policy and Legislative Changes

Policy changes, such as the implementation of upper payment limits or price negotiation authorities, can also influence drug prices. For example, the Inflation Reduction Act of 2022 introduced price negotiation mechanisms for Medicare, which could have broader implications for the pharmaceutical market[2].

Key Takeaways

  • Current Pricing: The current price per unit for Progesterone 100 mg capsules with NDC 69452-0233 is approximately $0.21.
  • Market Trends: Overall pharmaceutical expenditures are expected to rise by 10-12% in 2024, driven by increased utilization, new drug approvals, and price increases.
  • Regulatory Transparency: FDA's NDC Directory and state-level transparency initiatives provide crucial data on drug pricing and availability.
  • Market Factors: Utilization, new drug approvals, patent expirations, and policy changes are key factors influencing drug prices.

FAQs

What is the current price of Progesterone 100 mg capsules with NDC 69452-0233?

The current price per unit for Progesterone 100 mg capsules with NDC 69452-0233 is approximately $0.21 per capsule[5].

How are pharmaceutical expenditures expected to change in 2024?

Overall prescription drug expenditures in the US are expected to rise by 10-12% in 2024, with a 11-13% increase in clinics and a 0-2% increase in nonfederal hospitals[3].

What factors influence the price of Progesterone and similar drugs?

Factors such as increased utilization, new drug approvals, patent expirations, and policy changes can influence the price of Progesterone and similar drugs[2][3].

How does the FDA's NDC Directory impact drug pricing transparency?

The FDA's NDC Directory provides detailed information on drug listings, including marketing start and end dates, which helps in tracking price and availability changes over time[1].

Are there any policy changes that could affect the pricing of Progesterone?

Yes, policy changes such as the implementation of upper payment limits or price negotiation authorities can influence drug prices. For example, the Inflation Reduction Act of 2022 introduced price negotiation mechanisms for Medicare[2].

What is the significance of drug price transparency initiatives?

Drug price transparency initiatives aim to provide clearer insights into the factors influencing drug prices, helping to address gaps in transparency and potentially stabilize or reduce price volatility[2].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.